Skip to content
Congress·In Committee·12 months ago

Medicare: Discount Rules for Specific Oral Medications

Also known as: Ensuring Access to Essential Drugs Act

Legislative Progress

Filed
Review
House
Senate
President

Key Points

  • Congress is looking to change the rules for which drugs must offer discounts under Medicare. This plan focuses on specific medications that people take by mouth, such as pills or liquids, rather than injections.
  • Under current law, drug makers often have to give Medicare a discount on brand-name drugs to help lower costs. This bill would stop those mandatory discounts for a small group of drugs that the government already treats more like generic medicines because of their unique status.
  • The change is meant to help keep these specific drugs on the market. If a drug is already priced lower like a generic, requiring extra discounts could make it difficult for companies to keep producing them, which might lead to medicine shortages for seniors.
  • This policy would mostly affect drug manufacturers and the federal Medicare budget. For everyday Americans, the goal is to make sure that these essential medications stay available at the pharmacy without interruption.

Milestones

2 milestones2 actions
Mar 6, 2025House

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Mar 6, 2025

Introduced in House

Source Information

Document Type

Congressional Bill

Official Title

Ensuring Access to Essential Drugs Act

Bill NumberHR 1922
Congress119th Congress
ChamberHouse of Representatives
Latest ActionReferred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Cosponsors

(2)
D: 1R: 1

Analysis generated by AI. While we strive for accuracy, this should not be considered legal or professional advice. Always verify information with official government sources.